EBI OSTEOSTIM GRANULES-RESORBABLE BONE GRAFT SUBSTITUTE— 510(k) K011386

Name: FDA 510(k) clearance K011386
Creator: U.S. Food and Drug Administration
Published: 2001-08-03

Substantially Equivalent

Ebi, L.P.

FDA 510(k) clearance K011386 for EBI OSTEOSTIM GRANULES-RESORBABLE BONE GRAFT SUBSTITUTE, Substantially Equivalent on 2001-08-03. Applicant: Ebi, L.P.. Device class: 2.

Clearance details

Applicant: Ebi, L.P.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2001-05-07
Decision date: 2001-08-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Parsippany, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Ebi, L.P.

view all

K100438 — POLARIS SPINAL SYSTEM, POLARIS/SYNERGY STRUCTURE ANTERIOR FIXATION SYSTEM2010-06-23
K100220 — POLARIS SPINAL SYSTEM2010-05-17
K093880 — PEANUT GROWTH CONTROL PLATING SYSTEM2010-04-16
K092574 — ESL SPINAL SYSTEM2010-02-04
K093057 — BIOMET VISION FOOTRING SYSTEM2009-12-01

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.